Advertisement

Cell and Tissue Research

, Volume 374, Issue 3, pp 487–495 | Cite as

miR-451 elevation relieves inflammatory pain by suppressing microglial activation-evoked inflammatory response via targeting TLR4

  • Xiaojuan Sun
  • Hongxing ZhangEmail author
Regular Article

Abstract

Microglia-mediated neuroinflammation in spinal cord fulfills the pivotal role in the pathogenesis of chronic inflammatory pain. Emerging evidence confirms the anti-inflammatory effects of microRNA (miR)-451 in several inflammation-related diseases. Nevertheless, its function in the development of inflammatory pain is still poorly defined. In this study, the expression of miR-451 was decreased in spinal dorsal horn and spinal microglia of complete Freund’s adjuvant (CFA)-induced inflammatory pain mice model. In vitro, the ectopic expression of miR-451 inhibited LPS-triggered microglial activation by reducing NO production and microglia marker IBA-1 expression. Notably, miR-451 overexpression antagonized microglial activation-induced pro-inflammatory cytokine transcripts and releases, including IL-6, IL-1β, and TNF-α. Mechanism analysis corroborated that miR-451 elevation abrogated LPS-induced expression of TLR4, which was identified as a direct target of miR-451 by bioinformatics and a dual-firefly luciferase reporter assay. Intriguingly, overexpression of miR-451 counteracted the inhibitory effects of miR-451 on microglia inflammation. Additionally, restoring miR-451 expression in vivo alleviated CFA-evoked mechanical allodynia and thermal hyperalgesia in an inflammatory pain model. Concomitantly, administration of miR-451 lentiviral particles also attenuated CFA-induced inflammatory response and microglia activation, concomitant with a reduction in TLR4 expression in spinal cord. Collectively, the current research suggests that miR-451 may relieve chronic inflammatory pain by inhibiting microglia activation-mediated inflammation via targeting TLR4, supporting a promising approach for inflammatory pain therapy.

Keywords

Inflammatory pain mir-451 Microglial activation Inflammation TLR4 

Notes

Compliance with ethical standards

For experiments in mice, all protocols were conducted in accordance with the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals, and approved by the Institutional Animal Care and Use Committee of Xi’an Jiaotong University Health Science Center, Honghui Hospital.

Conflicts of interest

The authors declare that they have no conflict of interest.

Statement on the welfare of animals

All procedures performed in studies involving animals were performed according to the National Institutes of Health guide for the care and use of Laboratory animals, and approved by the Institutional Animal Care and Use Committee of Xi’an Jiaotong University Health Science Center, Honghui Hospital.

References

  1. Agalave NM, Larsson M, Abdelmoaty S, Su J, Baharpoor A, Lundback P, Palmblad K, Andersson U, Harris H, Svensson CI (2014) Spinal HMGB1 induces TLR4-mediated long-lasting hypersensitivity and glial activation and regulates pain-like behavior in experimental arthritis. Pain 155:1802–1813CrossRefGoogle Scholar
  2. Bedini A, Spampinato SM (2017) Innovative opioid peptides and biased Agonism: novel avenues for more effective and safer analgesics to treat chronic pain. Curr Med ChemGoogle Scholar
  3. Carniglia L, Ramirez D, Durand D, Saba J, Turati J, Caruso C, Scimonelli TN, Lasaga M (2017) Neuropeptides and microglial activation in inflammation, pain, and neurodegenerative diseases. Mediat Inflamm 2017:5048616CrossRefGoogle Scholar
  4. Eccleston C, Cooper TE, Fisher E, Anderson B, Wilkinson NM (2017) Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents. Cochrane Database Syst Rev 8:CD012537PubMedGoogle Scholar
  5. Guan Z, Hellman J, Schumacher M (2016) Contemporary views on inflammatory pain mechanisms: TRPing over innate and microglial pathways. F1000Res 5:Google Scholar
  6. Hines DJ, Choi HB, Hines RM, Phillips AG, MacVicar BA (2013) Prevention of LPS-induced microglia activation, cytokine production and sickness behavior with TLR4 receptor interfering peptides. PLoS One 8:e60388CrossRefGoogle Scholar
  7. Hur W, Lee JH, Kim SW, Kim JH, Bae SH, Kim M, Hwang D, Kim YS, Park T, Um SJ, Song BJ, Yoon SK (2015) Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway. Int J Biochem Cell Biol 64:265–276CrossRefGoogle Scholar
  8. Lee YC (2013) Effect and treatment of chronic pain in inflammatory arthritis. Curr Rheumatol Rep 15:300CrossRefGoogle Scholar
  9. Liu CC, Cheng JT, Li TY, Tan PH (2017) Integrated analysis of microRNA and mRNA expression profiles in the rat spinal cord under inflammatory pain conditions. Eur J Neurosci 46:2713–2728CrossRefGoogle Scholar
  10. Lu Y, Zhao LX, Cao DL, Gao YJ (2013) Spinal injection of docosahexaenoic acid attenuates carrageenan-induced inflammatory pain through inhibition of microglia-mediated neuroinflammation in the spinal cord. Neuroscience 241:22–31CrossRefGoogle Scholar
  11. Madeira MH, Boia R, Santos PF, Ambrosio AF, Santiago AR (2015) Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases. Mediat Inflamm 2015:673090CrossRefGoogle Scholar
  12. Moniruzzaman M, Bose S, Kim YM, Chin YW, Cho J (2016) The ethyl acetate fraction from Physalis alkekengi inhibits LPS-induced pro-inflammatory mediators in BV2 cells and inflammatory pain in mice. J Ethnopharmacol 181:26–36CrossRefGoogle Scholar
  13. Old EA, Clark AK, Malcangio M (2015) The role of glia in the spinal cord in neuropathic and inflammatory pain. Handb Exp Pharmacol 227:145–170CrossRefGoogle Scholar
  14. Rasu RS, Vouthy K, Crowl AN, Stegeman AE, Fikru B, Bawa WA, Knell ME (2014) Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States. J Manag Care Spec Pharm 20:921–928PubMedGoogle Scholar
  15. Regen F, Hellmann-Regen J, Costantini E, Reale M (2017) Neuroinflammation and Alzheimer's disease: implications for microglial activation. Curr Alzheimer Res 14:1140–1148CrossRefGoogle Scholar
  16. Shen WS, Xu XQ, Zhai NN, Zhou ZS, Shao J, Yu YH (2017) Potential mechanisms of microRNA-141-3p to alleviate chronic inflammatory pain by downregulation of downstream target gene HMGB1: in vitro and in vivo studies. Gene Ther 24:353–360CrossRefGoogle Scholar
  17. Shi G, Shi J, Liu K, Liu N, Wang Y, Fu Z, Ding J, Jia L, Yuan W (2013) Increased miR-195 aggravates neuropathic pain by inhibiting autophagy following peripheral nerve injury. Glia 61:504–512CrossRefGoogle Scholar
  18. Su M, Ran Y, He Z, Zhang M, Hu G, Tang W, Zhao D, Yu S (2018) Inhibition of toll-like receptor 4 alleviates hyperalgesia induced by acute dural inflammation in experimental migraine. Mol Pain 14:1744806918754612PubMedPubMedCentralGoogle Scholar
  19. Sun Y, Peng R, Peng H, Liu H, Wen L, Wu T, Yi H, Li A, Zhang Z (2016) miR-451 suppresses the NF-kappaB-mediated proinflammatory molecules expression through inhibiting LMP7 in diabetic nephropathy. Mol Cell Endocrinol 433:75–86CrossRefGoogle Scholar
  20. Tanga FY, Nutile-McMenemy N, DeLeo JA (2005) The CNS role of toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci U S A 102:5856–5861CrossRefGoogle Scholar
  21. Yu Z, Tang L, Chen L, Li J, Wu W, Hu C (2015) Capillarisin suppresses lipopolysaccharide-induced inflammatory mediators in BV2 microglial cells by suppressing TLR4-mediated NF-kappaB and MAPKs signaling pathway. Neurochem Res 40:1095–1101CrossRefGoogle Scholar
  22. Zhang J, Deng X (2017) Bupivacaine effectively relieves inflammation-induced pain by suppressing activation of the NF-kappaB signalling pathway and inhibiting the activation of spinal microglia and astrocytes. Exp Ther Med 13:1074–1080CrossRefGoogle Scholar
  23. Zhang Z, Gao X, Cao Y, Jiang H, Wang T, Song X, Guo M, Zhang N (2015) Selenium deficiency facilitates inflammation through the regulation of TLR4 and TLR4-related signaling pathways in the mice uterus. Inflammation 38:1347–1356CrossRefGoogle Scholar
  24. Zhao XH, Zhang T, Li YQ (2015) The up-regulation of spinal toll-like receptor 4 in rats with inflammatory pain induced by complete Freund's adjuvant. Brain Res Bull 111:97–103CrossRefGoogle Scholar
  25. Zhu MD, Zhao LX, Wang XT, Gao YJ, Zhang ZJ (2014) Ligustilide inhibits microglia-mediated proinflammatory cytokines production and inflammatory pain. Brain Res Bull 109:54–60CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of AnesthesiologyThe Hospital of Chinese Traditional Medicine of LeshanLeshanPeople’s Republic of China
  2. 2.Department of Hand Surgery, Xi’an Jiaotong University Health Science CenterHonghui HospitalXi’anPeople’s Republic of China

Personalised recommendations